Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Syngene International Ltd. ( (IN:SYNGENE) ) has shared an update.
Syngene International Ltd. announced the approval of its audited financial results for the quarter and year ending March 31, 2025, and recommended a final dividend of Re.1.25 per equity share. The board also approved the appointment of V Sreedharan & Associates as secretarial auditors and decided on several corporate governance matters, including managerial remuneration and amendments to incentive plans, all subject to shareholder approval.
More about Syngene International Ltd.
Syngene International Ltd. operates in the biotechnology sector, providing integrated research, development, and manufacturing services. The company focuses on delivering scientific solutions to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
YTD Price Performance: -14.61%
Average Trading Volume: 44,654
Current Market Cap: 296B INR
For an in-depth examination of SYNGENE stock, go to TipRanks’ Stock Analysis page.